|
Title
|
|
|
|
Is []fluorodeoxyglucose positron emission tomography the ultimate tool for response and prognosis assessment?
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| [18F]fluorodeoxyglucose positron emission tomography (FDG-PET) is currently the most accurate and reliable tool for the assessment of response in Hodgkin's lymphoma (HL). FDG-PET is superior to conventional imaging techniques for detection of residual disease at the end of treatment, especially in the presence of a residual mass, a frequent finding in HL. FDG-PET response assessment has also a high predictive value early after the initiation of therapy. However, whether risk-adapted treatment strategies based on FDG-PET may also improve patient outcome remains to be proved. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Hematology and oncology clinics of North America. - Philadelphia, Pa, 1987, currens
|
|
|
Publication
|
|
|
|
Philadelphia, Pa
:
2007
|
|
|
ISSN
|
|
|
|
0889-8588
1558-1977
[online]
|
|
|
DOI
|
|
|
|
10.1016/J.HOC.2007.07.003
|
|
|
Volume/pages
|
|
|
|
21
:5
(2007)
, p. 855-869
|
|
|
ISI
|
|
|
|
000250495500007
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|